- Investing Ideas
- Global Pharmaceuticals & Biotech Profitable Climbers
Global Pharmaceuticals & Biotech Profitable Climbers
Results
135
135 companies
Zevra Therapeutics
Market Cap: US$484.2m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.60
7D
-4.4%
1Y
10.7%
Alnylam Pharmaceuticals
Market Cap: US$43.4b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$328.16
7D
-3.2%
1Y
19.7%
Corcept Therapeutics
Market Cap: US$4.3b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$40.83
7D
0.3%
1Y
-39.5%
Rubicon Research
Market Cap: ₹129.3b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹784.65
7D
15.6%
1Y
n/a
Camurus
Market Cap: SEK 40.9b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 686.50
7D
-0.07%
1Y
15.1%
Anthem Biosciences
Market Cap: ₹366.7b
Operates as technology-focused contract research, development, and manufacturing organization.
ANTHEM
₹652.90
7D
11.1%
1Y
n/a
PharmaEssentia
Market Cap: NT$267.4b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$723.00
7D
-6.1%
1Y
14.8%
Bonesupport Holding
Market Cap: SEK 11.3b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 171.50
7D
-7.3%
1Y
-51.7%
ChengDu ShengNuo BiotecLtd
Market Cap: CN¥6.1b
Engages in the research and development, production, sale, and export of peptide drugs.
688117
CN¥38.84
7D
-0.4%
1Y
115.7%
Xiamen Amoytop Biotech
Market Cap: CN¥28.2b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥69.11
7D
-9.1%
1Y
-14.0%
Wedge IndustrialLtd
Market Cap: CN¥14.0b
Engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.
000534
CN¥29.05
7D
-1.1%
1Y
95.1%
Alvotech
Market Cap: US$1.6b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$5.12
7D
-4.7%
1Y
-60.3%
Lotus Pharmaceutical
Market Cap: NT$87.2b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$331.50
7D
-8.2%
1Y
19.2%
Acutaas Chemicals
Market Cap: ₹162.7b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹1,986.90
7D
8.9%
1Y
59.4%
WuXi XDC Cayman
Market Cap: HK$79.3b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$63.05
7D
0.4%
1Y
105.4%
Newron Pharmaceuticals
Market Cap: CHF 382.3m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 19.10
7D
-4.5%
1Y
96.1%
Aether Industries
Market Cap: ₹134.2b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹1,011.30
7D
0.6%
1Y
17.4%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$32.1b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$47.70
7D
8.7%
1Y
519.5%
Concord Biotech
Market Cap: ₹138.8b
A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.
CONCORDBIO
₹1,327.20
7D
16.5%
1Y
-43.4%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥12.1b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥17.51
7D
2.7%
1Y
18.0%
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
Market Cap: ج.م7.0b
Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.
RMDA
ج.م3.52
7D
10.7%
1Y
30.5%
Kexing Biopharm
Market Cap: CN¥6.3b
A biopharmaceutical company, engages in the research and development, production, and sale of recombinant protein drugs and microecological preparations in China, the European Union, Brazil, the Philippines, and Indonesia.
688136
CN¥31.66
7D
-2.7%
1Y
69.8%
Hualan Biological Vaccine
Market Cap: CN¥13.0b
Engages in the research and development, production, and sale of vaccines and genetic engineering biological products in China.
301207
CN¥21.90
7D
-0.2%
1Y
20.4%
Pharma Mar
Market Cap: €1.3b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, China, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€76.25
7D
-0.5%
1Y
-18.3%
KPC PharmaceuticalsInc
Market Cap: CN¥9.5b
A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally.
600422
CN¥12.53
7D
0.3%
1Y
-23.2%
Boji Medical TechnologyLtd
Market Cap: CN¥4.0b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥10.52
7D
-0.8%
1Y
14.7%
Cohance Lifesciences
Market Cap: ₹129.9b
Engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.
COHANCE
₹339.45
7D
-8.2%
1Y
-70.7%
Orchid Pharma
Market Cap: ₹34.5b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹680.55
7D
-0.2%
1Y
-51.4%
CORONA Remedies
Market Cap: ₹94.0b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹1,537.30
7D
6.1%
1Y
n/a
Eris Lifesciences
Market Cap: ₹198.2b
Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.
ERIS
₹1,431.00
7D
3.3%
1Y
-3.2%
Innova Captab
Market Cap: ₹40.5b
An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.
INNOVACAP
₹707.65
7D
2.0%
1Y
-23.5%
Bora Pharmaceuticals
Market Cap: NT$69.2b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$558.00
7D
-7.5%
1Y
-21.6%
May & Baker Nigeria
Market Cap: ₦68.1b
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
MAYBAKER
₦39.50
7D
6.2%
1Y
338.9%
Kiniksa Pharmaceuticals International
Market Cap: US$3.3b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$43.09
7D
-3.5%
1Y
119.8%
Oncodesign Precision Medicine Société anonyme
Market Cap: €10.0m
A biopharmaceutical company, engages in the precision medicine business.
ALOPM
€0.55
7D
-4.2%
1Y
-8.0%
Emcure Pharmaceuticals
Market Cap: ₹287.3b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,515.70
7D
2.0%
1Y
25.0%